Nectar Lifesciences P/B Ratio
Nectar Lifesciences (NECLIFE) P/B ratio is 0.34 (Low), book value per share ₹434.55 vs Healthcare average P/B of -0.98 — Very Low - Significant discount to book value, potential distress or value opportunity. For live price, earnings yield and the full fundamental profile, see NECLIFE share price.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
NECLIFE P/B Ratio — Valuation Insights & Book Value Analysis
Nectar Lifesciences price-to-book ratio interpretation, valuation status and historical context — current P/B 0.34 (Low).
- Stock appears undervalued with PB of 0.34, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 448.4% above historical average
- Trading at premium to sector average PB of -0.98
Nectar Lifesciences P/B Ratio Historical Trend
NECLIFE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Browse NECLIFE quarterly financials for revenue, profit, balance sheet and cash flow data.
NECLIFE Historical P/B Ratio — Book Value Per Share & Year-End Price
Nectar Lifesciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.05 | ₹434.55 | ₹20.90 | ₹956 | Low |
| 2024 | 0.08 | ₹485.91 | ₹39.00 | ₹1,069 | Low |
| 2023 | 0.07 | ₹484.09 | ₹32.16 | ₹1,065 | Low |
| 2022 | 0.05 | ₹494.55 | ₹24.45 | ₹1,088 | Low |
| 2021 | 0.06 | ₹482.73 | ₹26.85 | ₹1,062 | Low |
NECLIFE vs Healthcare Peers — P/B Ratio Comparison
Nectar Lifesciences P/B 0.34 vs Healthcare average -0.98, median 0.65 — range -36.63–1.06.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |